Selection procedure reference: EMA/TR/11425
Deadline for applications: 06 May 2026 23:59 CET
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee in the Therapeutic Areas Department.
Specific objectives and projects
The Office for Vaccines and therapies for infectious diseases (H-TA-INF) manages the benefit-risk assessment of medicinal products related to infectious diseases, including antivirals, antibiotics, antiparasitics, antifungals and vaccines, throughout their lifecycle. In this context, maintaining oversight of all centrally approved antibiotics and antifungals is essential, to support the preparation of key meetings, the preparation of EMA annual reports and addressing internal and external queries.
The objective of this traineeship is to create a database recording historical information of approved products as well as an overview of currently ongoing procedures, prospective forthcoming applications, and all relevant pre-submission interactions with EMA. The data used to populate the database will be retrieved from an exisiting internal EMA database and completed as needed with information from EMA assessment reports and/or publicly available information. The database is expected to include functionalities enabling easy visualisation of information and allowing sub-analyses (e.g. approval patterns over time, paediatric use, route of administration, break-down of therapeutic indications etc), so a critical review and harmonisation of the structure and format of the data will be required as well as experience in database creation or data management and visualisation.
Learning outcomes
By the end of this traineeship, the trainee will
-
Achieve increased knowledge of the the functioning of the European Medicines Agency (EMA) and its scientific committees, the centralised marketing authorisation procedure and the EU regulatory network
-
Achieve in-depth regulatory knowledge and experience in the area of antimicrobial resistance (AMR), antibiotics, antifungals
-
Experience working in a multi-cultural and international environment
-
Develop technical and soft skills such as communication and project management
Eligibility criteria
To be eligible for consideration for this placement, you are required to:
-
enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
-
possess a university degree in life science (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
-
a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
Additional skills
-
Pharmaceutical / microbiology background
-
Good project management skills and knowledge of different IT systems
-
Good communication skills
-
Good analytical and organisational skills
Behavioural Competencies
You will demonstrate the following behavioural competencies:
Conditions of traineeship
The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.
The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.
Each trainee will have a mentor at the Agency who will guide the trainee through the programme.
The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here .
Expected selection timelines
Deadline for applications
06 May 2026 23:59 CET
Assessments (remote)
From mid-June 2026 to mid-July 2026
Decision and offers
By end of July 2026
Placement start
1 October 2026
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu
© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.